Somatostatin receptor ligands (SRLs) or somatostatin analogs (SSTA) are first-line pharmacological treatment choices for acromegaly, which received satisfying tumor shrinkage and normalization of growth hormone. The gene discussed is GH1; the disease is neoplasm.